Bleeding

Released on 12/04/2018

Key Learning Points

  • BCG immunotherapy
  • BCG maintenance therapy
  • Diagnosis of bladder cancer
  • Evaluation of extension to the upper urinary tract
  • Evaluation of hematuria
  • Followup of NMIBC
  • Indications for random bladder biopsies and prostatic urethra biopsy
  • Indications for upper urinary tract imaging
  • Intravesical therapy for NMIBC
  • Metformin and contrast material
  • Repeat TURBT in bladder cancer diagnosis
  • TNM staging
  • Transitional call carcinoma (TCC)
  • Transurethral Resection of Bladder Tumor (TURBT)
  • Tumor markers in the detection of bladder cancer
  • Urine cytology in the evaluation of hematuria
  • When to repeat TUR

References

1. KASSOUF W, APRIKIAN A, BLACK P, KULKARNI G, IZAWA J, EAPEN L, FAIREY A, SO A, NORTH S, RENDON R, SRIDHAR SS, ALAM T, BRIMO F, BLAIS N, BOOTH C, CHIN J, CHUNG P, DRACHENBERG D, FRADET Y, JEWETT M, MOORE R, MORASH C, SHAYEGAN B, GOTTO G, FLESHNER N, SAAD F, SIEMENS DR. Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015 Can Urol Assoc J [online] 2016 Feb 8, 10(1-2):E46-E80 [viewed 27 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771569
2. ANASTASIADIS A, DE REIJKE TM. Best practice in the treatment of nonmuscle invasive bladder cancer Ther Adv Urol [online] 2012 Feb, 4(1):13-32 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263923
3. WOLDU SL, BAGRODIA A, LOTAN Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int [online] 2017 Mar, 119(3):371-380 [viewed 27 June 2017] Available from: DOI: 10.1111/bju.13760
4. CHEUNG G, SAHAI A, BILLIA M, DASGUPTA P, KHAN MS. Recent advances in the diagnosis and treatment of bladder cancer BMC Med [online] 2013 Jan 17:13 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566975
5. MARTYN-HEMPHILL C, MAK D, KHAN MS, CHALLACOMBE BJ, BISHOP CV. Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder. Int J Surg [online] 2013, 11(9):749-52 [viewed 28 June 2017] Available from: Doi: 10.1016/j.ijsu.2013.08.018
6. CAO M, YANG G, PAN J, SUN J, CHEN Q, CHEN Y, CHEN H, XUE W. Repeated transurethral resection for non-muscle invasive bladder cancer Int J Clin Exp Med [online] 2015 Jan 15, 8(1):1416-1419 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358603
7. TSAKIRIS P, DE LA ROSETTE J. Imaging in genitourinary cancer from the urologists' perspective Cancer Imaging [online] 2007 May 28, 7(1):84-92 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1931512
8. POWER NE, IZAWA J. Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE) Bl Cancer [online] 2016 Jan 7, 2(1):27-36 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927900
9. SHAH AD, MCHARGUE C, YEE J, RUSHAKOFF RJ. INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES. Endocr Pract [online] 2016 Apr, 22(4):502-5 [viewed 28 June 2017] Available from: DOI: 10.4158/EP151123.CO
10. CLARK PE, SPIESS PE, AGARWAL N, BANGS R, BOORJIAN SA, BUYYOUNOUSKI MK, EFSTATHIOU JA, FLAIG TW, FRIEDLANDER T, GREENBERG RE, GURU KA, HAHN N, HERR HW, HOIMES C, INMAN BA, KADER AK, KIBEL AS, KUZEL TM, LELE SM, MEEKS JJ, MICHALSKI J, MONTGOMERY JS, PAGLIARO LC, PAL SK, PATTERSON A, PETRYLAK D, PLIMACK ER, POHAR KS, PORTER MP, SEXTON WJ, SIEFKER-RADTKE AO, SONPAVDE G, TWARD J, WILE G, DWYER MA, SMITH C. NCCN Guidelines® Insights Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines J Natl Compr Canc Netw [online] 2016 Oct, 14(10):1213-1224 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379654
11. PIRZADA MT, GHAURI R, AHMED MJ, SHAH MF, NASIR IU, SIDDIQUI J, AHMED I, MIR K. Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study Cureus [online] 2017 Jan 5, 9(1):e957 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291702
12. GREGG JR, DAHM P, CHANG SS. Guideline-based management of non-muscle invasive bladder cancer Indian J Urol [online] 2015 Oct-Dec, 31(4):320-326 [viewed 28 June 2017] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626916
13. BABJUK M, BöHLE A, BURGER M, CAPOUN O, COHEN D, COMPéRAT EM, HERNáNDEZ V, KAASINEN E, PALOU J, ROUPRêT M, VAN RHIJN BW, SHARIAT SF, SOUKUP V, SYLVESTER RJ, ZIGEUNER R. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol [online] 2017 Mar, 71(3):447-461 [viewed 25 October 2017] Available from: Doi: 10.1016/j.eururo.2016.05.041